{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:18:03Z","timestamp":1769422683268,"version":"3.49.0"},"reference-count":13,"publisher":"Georg Thieme Verlag KG","issue":"09","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":146,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1055\/s-0045-1813233","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T23:35:30Z","timestamp":1769384130000},"page":"001-002","source":"Crossref","is-referenced-by-count":0,"title":["Patient journey and treatment pattern in myasthenia gravis: real-world data from the Brazilian public health system"],"prefix":"10.1055","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-5317","authenticated-orcid":false,"given":"Rosana Herminia","family":"Scola","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1, Departamento de Medicina Interna, Disciplina de Neurologia, Curitiba PR, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"issue":"09","key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0045-1811720","article-title":"Patient journey and treatment pattern in myasthenia gravis: real-world data from the Brazilian public health system","volume":"83","author":"R Andrade","year":"2025","journal-title":"Arq Neuropsiquiatr"},{"issue":"11","key":"ref2","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"L Dresser","year":"2021","journal-title":"J Clin Med"},{"issue":"12","key":"ref3","doi-asserted-by":"publisher","first-page":"e50017","DOI":"10.7759\/cureus.50017","article-title":"Myasthenia gravis: a systematic review","volume":"15","author":"A K Mishra","year":"2023","journal-title":"Cureus"},{"issue":"02","key":"ref4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0022-510X(91)90260-E","article-title":"Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients","volume":"106","author":"E Beghi","year":"1991","journal-title":"J Neurol Sci"},{"issue":"01","key":"ref5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"L C Wendell","year":"2011","journal-title":"Neurohospitalist"},{"issue":"07","key":"ref6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/acn3.51792","article-title":"Mortality of myasthenia gravis: a national population-based study in China","volume":"10","author":"C Zhang","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"ref7","volume-title":"Protocolos cl\u00ednicos e diretrizes terap\u00eauticas da miastenia grave","author":"Minist\u00e9rio da Sa\u00fade (Brasil)","year":"2020"},{"issue":"03","key":"ref8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1474-4422(24)00028-0","article-title":"Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study","volume":"23","author":"P Narayanaswami","year":"2024","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"120480","DOI":"10.1016\/j.jns.2022.120480","article-title":"Real-world utilization patterns of intravenous immunoglobulin in adults with generalized myasthenia gravis in the United States","volume":"443","author":"C Z Qi","year":"2022","journal-title":"J Neurol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Y Guo","year":"2018","journal-title":"Front Immunol"},{"issue":"01","key":"ref11","doi-asserted-by":"publisher","first-page":"e000241","DOI":"10.1136\/bmjmed-2022-000241","article-title":"New and emerging treatments for myasthenia gravis","volume":"2","author":"M DeHart-McCoyle","year":"2023","journal-title":"BMJ Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"578718","DOI":"10.1016\/j.jneuroim.2025.578718","article-title":"Clinical utility of autoantibodies in the diagnosis and management of Myasthenia gravis","volume":"407","author":"S El-Wahsh","year":"2025","journal-title":"J Neuroimmunol"},{"issue":"03","key":"ref13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial","volume":"18","author":"G I Wolfe","year":"2019","journal-title":"Lancet Neurol"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1813233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T23:35:31Z","timestamp":1769384131000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1813233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":13,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2025,6,21]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["s00451813233"],"URL":"https:\/\/doi.org\/10.1055\/s-0045-1813233","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}